Recro Gainesville Adds Manufacturing Capacity
PTSM: Pharmaceutical Technology Sourcing and Management
Recro Gainsville expands its tableting capacity with the addition of a tablet press and film coater.
Recro Gainesville, LLC, wholly-owned subsidiary of Recro Pharma, Inc., announced on May 24, 2017 the expansion of its capabilities with the addition of a tablet manufacturing suite and growing its development team.
The company’s new suite includes a Fette FE 55 tablet press, which will enable the company to compress single- and bi-layer tablets at commercial speeds, and a Bohle BTC-100 film coater.
“As long-term leaders in the development of extended release technology, we pride ourselves in meeting our clients’ exact standards,” said Scott Rizzo, general manager, in a press release. “By expanding our equipment line and adding nearly a dozen more scientists to our team, we are able to offer yet more services to meet our clients’ needs.”
Recro offers formulation, reformulation, analytical method development, manufacturing and packaging, and logistics services and can take delayed release, sustained release, or combination release products from development to commercialization.
Source: Recro Gainsville
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
